FindTrial
Sign In

Cannabis Extract Avextra 10/10 Solution

DRUG3 trials

Sponsors

Azienda Ospedaliero-Universitaria Maggiore Della Carita, Universitaetsklinikum Schleswig-Holstein AöR, IRCCS Istituto Nazionale Tumori Fondazione Pascale

Conditions

Alzheimer’s Disease (AD) and Parkinson’s Disease (PD).Patients suffering from neurodegenerative diseases: Amyotrophic Lateral Sclerosis (ALS)Patients with advanced oncologic disease receiving active treatment with WHO level II or III opioids and adjuvants therapiesoncologypalliative carequality of life

Phase 2

MEDICAL CANNABIS FOR NEURODEGENERATIVE DISEASES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II CLINICAL TRIAL (NEUROBIS)
Not yet recruitingCTIS2023-507715-35-02
Azienda Ospedaliero-Universitaria Maggiore Della CaritaAlzheimer’s Disease (AD) and Parkinson’s Disease (PD)., Patients suffering from neurodegenerative diseases: Amyotrophic Lateral Sclerosis (ALS)
Target: 186Updated: 2024-07-17
Improvement of Quality of Life by Cannabinoids in Oncologic Patients (BELCANTO)
RecruitingCTIS2024-518917-24-00
Universitaetsklinikum Schleswig-Holstein AöRoncology, palliative care, quality of life
Start: 2023-11-08Target: 170Updated: 2025-10-29
Cannabis extrAct in oncology Patients for the treatment of TUmor Related symptom burden (CAPTURE)
Not yet recruitingCTIS2024-519568-42-00
IRCCS Istituto Nazionale Tumori Fondazione PascalePatients with advanced oncologic disease receiving active treatment with WHO level II or III opioids and adjuvants therapies
Target: 156Updated: 2026-01-16